1 / 23

NF1 Neurofibromatosis

NF1 Neurofibromatosis. Presented by: Jacqueline Holt March 4 th 2003. Objectives. Identity NF1 gene Biochemistry of NF1 Mutations in NF1 NF1 and cancer (Neurofibromatosis). Located on chromosome 17q11.2. Identity NF1 gene.

zudora
Download Presentation

NF1 Neurofibromatosis

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. NF1Neurofibromatosis Presented by: Jacqueline Holt March 4th 2003

  2. Objectives • Identity NF1 gene • Biochemistry of NF1 • Mutations in NF1 • NF1 and cancer (Neurofibromatosis)

  3. Located on chromosome 17q11.2

  4. Identity NF1 gene • NF1 expressed in all tissues of human, rat, mouse; higher in nervous tissues • Encodes a protein Neurofibromin made of 2839 amino acids; 220kD

  5. Biochemistry NF1 • Neurofibromin- most abundant in nervous system • Large and complex signaling protein • Tumor Suppressor in nervous system

  6. Biochemistry of NF1 Contains a functional GAP-related domain (GRD)

  7. Biochemistry of NF1 • Homologous to the GTPase activating protein (GAP) family member: p120ras • GAP proteins turn off the ras signal by converting GTP (active) to GDP (inactive)

  8. RAS Pathway • Ras regulates proliferation and differentiation

  9. NF1 Pathway • NF1 appears to be a negative regulator of the RAS signal transduction pathway via its GAP activity domain • Tumor suppressor

  10. NF1 Knockout Mice • NF1 heterozygous (NF1 +/-) are viable, but develop malignancies; myeloid leukemia • Homozygous (NF1 -/-) died with heart defects • Helped with characterization of NF1 function in cell types that are affected in NF1 tumors

  11. Mutations in NF1 • Mutation in one copy is enough to produce benign tumors and other symptoms • subcutaneous • Need mutation in both copies of alleles to form malignant tumors • MPNST (malignant peripheral nerve sheath tumor)

  12. Mutations in NF1 • Examination of NF1 malignant tumor cell lines showed a decrease or absence of neurofibromin expression • Loss of function results in deregulation of Ras activity • Results in high levels of active Ras-GTP • Results in increase in cell proliferation • Schwann cells are primary target for mutation

  13. Test Neurofibromin Activity in a Cell!

  14. NF1 and p16 • p16 is a CDKI; prevents cyclinD binding to cdk4 • Analyzed cells with malignant and benign peripheral nerve tumors • Found that benign tumors did not have p16 deletions • Malignant tumors had p16 deletion • Malignant tumors associate with p16 deletion

  15. NF1 & Neurofibromatosis Identified by Friedrich Recklinghausen 1882 Most common inherited neurological disease Autosomal dominant 1 in 3,500- 4,000 50% cases are spontaneous 1 in 10,000 Primarily affects the development and growth of cells in nervous system

  16. NF1 & Neurofibromatosis • 2 major manifestations: • Neurofibromas and gliomas- benign tumors along peripheral and optic nerves

  17. Neurofibromas • Contain 4 cell types • Schwann cells • Neurons • Fibroblasts • Perineurial • 3 kinds of Tumors • Cutaneous • Interneural • Plexiform

  18. Café-au-lait spots • 1st symptoms of NF1 • Important for diagnosis • Benign

  19. Other symptoms include: • Lisch nodules • Short stature • Seizures • Learning and behavior dysfunction • Juvenile myeloid leukemia • Defects in bone structure

  20. Other symptoms include: • Lisch nodules • Short stature • Seizures • Learning and behavior dysfunction • Juvenile myeloid leukemia • Defects in bone structure

  21. Life expectancy 10-15 years • Malignancy most common cause of death • Treatments: • Laser removal of neurofibromas • Back braces or surgery • Educational intervention • Radiation • Chemotherapy

More Related